Stephen Baxter
Stock Analyst at Wells Fargo
(3.12)
# 1,207
Out of 5,090 analysts
231
Total ratings
47.02%
Success rate
0.19%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PNTG The Pennant Group | Upgrades: Overweight | $29 → $31 | $29.12 | +6.46% | 3 | Nov 18, 2025 | |
| OSCR Oscar Health | Maintains: Underweight | $14 → $11 | $16.77 | -34.41% | 13 | Nov 13, 2025 | |
| CVS CVS Health | Maintains: Overweight | $103 → $102 | $75.63 | +34.87% | 16 | Nov 13, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $249 → $259 | $231.08 | +12.08% | 16 | Nov 13, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $238 → $252 | $210.00 | +20.00% | 16 | Nov 13, 2025 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $412 → $431 | $486.70 | -11.44% | 17 | Nov 13, 2025 | |
| MOH Molina Healthcare | Maintains: Overweight | $231 → $165 | $151.86 | +8.65% | 21 | Nov 12, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $41 → $35 | $38.34 | -8.71% | 24 | Nov 12, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $33 → $39 | $35.79 | +8.97% | 7 | Nov 12, 2025 | |
| COR Cencora | Maintains: Overweight | $354 → $405 | $339.66 | +19.24% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $816 → $914 | $808.62 | +13.03% | 9 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1.5 → $1 | $0.65 | +53.33% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $265.44 | +13.02% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $185 → $221 | $198.83 | +11.15% | 9 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $412 → $403 | $330.75 | +21.84% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $267 → $400 | $330.91 | +20.88% | 15 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $344 → $347 | $257.85 | +34.57% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2.5 → $3 | $3.57 | -15.97% | 11 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.59 | +97.63% | 3 | Apr 29, 2024 |
The Pennant Group
Nov 18, 2025
Upgrades: Overweight
Price Target: $29 → $31
Current: $29.12
Upside: +6.46%
Oscar Health
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $16.77
Upside: -34.41%
CVS Health
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $75.63
Upside: +34.87%
Universal Health Services
Nov 13, 2025
Maintains: Overweight
Price Target: $249 → $259
Current: $231.08
Upside: +12.08%
Tenet Healthcare
Nov 13, 2025
Maintains: Overweight
Price Target: $238 → $252
Current: $210.00
Upside: +20.00%
HCA Healthcare
Nov 13, 2025
Maintains: Equal-Weight
Price Target: $412 → $431
Current: $486.70
Upside: -11.44%
Molina Healthcare
Nov 12, 2025
Maintains: Overweight
Price Target: $231 → $165
Current: $151.86
Upside: +8.65%
Centene
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $41 → $35
Current: $38.34
Upside: -8.71%
BrightSpring Health Services
Nov 12, 2025
Maintains: Overweight
Price Target: $33 → $39
Current: $35.79
Upside: +8.97%
Cencora
Nov 11, 2025
Maintains: Overweight
Price Target: $354 → $405
Current: $339.66
Upside: +19.24%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $816 → $914
Current: $808.62
Upside: +13.03%
Nov 5, 2025
Maintains: Overweight
Price Target: $1.5 → $1
Current: $0.65
Upside: +53.33%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $265.44
Upside: +13.02%
Nov 5, 2025
Maintains: Overweight
Price Target: $185 → $221
Current: $198.83
Upside: +11.15%
Oct 22, 2025
Maintains: Overweight
Price Target: $412 → $403
Current: $330.75
Upside: +21.84%
Oct 7, 2025
Maintains: Overweight
Price Target: $267 → $400
Current: $330.91
Upside: +20.88%
Oct 7, 2025
Maintains: Overweight
Price Target: $344 → $347
Current: $257.85
Upside: +34.57%
Oct 7, 2025
Maintains: Underweight
Price Target: $2.5 → $3
Current: $3.57
Upside: -15.97%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.59
Upside: +97.63%